Cas no 1076198-18-9 (ortho Gliclazide)

Ortho Gliclazide is a sulfonylurea derivative used primarily in the management of type 2 diabetes mellitus. It functions by stimulating insulin secretion from pancreatic beta cells, thereby improving glycemic control. Key advantages include its selective action on ATP-sensitive potassium channels, which enhances glucose-dependent insulin release and minimizes hypoglycemic risk. Ortho Gliclazide also exhibits antioxidant properties, potentially reducing oxidative stress associated with diabetes. Its modified-release formulation ensures prolonged pharmacokinetic stability, allowing for once-daily dosing and improved patient compliance. The compound demonstrates high bioavailability and low protein binding, contributing to consistent therapeutic effects. It is particularly suitable for patients requiring precise glycemic regulation with a reduced incidence of adverse effects.
ortho Gliclazide structure
ortho Gliclazide structure
Product Name:ortho Gliclazide
CAS No:1076198-18-9
MF:C15H21N3O3S
MW:323.41054224968
CID:1060002
PubChem ID:46780435
Update Time:2025-05-28

ortho Gliclazide Chemical and Physical Properties

Names and Identifiers

    • ortho Gliclazide
    • 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(2-methylphenyl)sulfonylurea
    • Gliclazide impurity F
    • 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl)sulphonyl]urea
    • N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-2-methylbenzenesulfonamide
    • STL450903
    • 1076198-18-9
    • ortho-Gliclazide
    • N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-2-methylbenzenesulfonamide
    • ortho Gliclazide (Gliclazide Impurity)
    • N-((Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-2-methylbenzenesulfonamide
    • N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-2-methyl benzenesulfonamide
    • DTXSID50675626
    • 1-(2-methylbenzenesulfonyl)-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea
    • N-[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl]-2-methylbenzene-1-sulfonamide
    • 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl)sulphonyl]urea; Gliclazide Imp. F (EP); Gliclazide Impurity F
    • N-[[(HEXAHYDROCYCLOPENTA [C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-2-METHYL BENZENESULFONAMIDE
    • Inchi: 1S/C15H21N3O3S/c1-11-5-2-3-8-14(11)22(20,21)17-15(19)16-18-9-12-6-4-7-13(12)10-18/h2-3,5,8,12-13H,4,6-7,9-10H2,1H3,(H2,16,17,19)
    • InChI Key: XLSAYFQNZDWDHT-UHFFFAOYSA-N
    • SMILES: S(C1C=CC=CC=1C)(NC(NN1CC2CCCC2C1)=O)(=O)=O

Computed Properties

  • Exact Mass: 323.13000
  • Monoisotopic Mass: 323.13
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 22
  • Rotatable Bond Count: 3
  • Complexity: 505
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 2
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 86.9A^2
  • XLogP3: 3

Experimental Properties

  • Density: 1.35±0.1 g/cm3 (20 oC 760 Torr),
  • Melting Point: 160 - 164°C
  • Solubility: Very slightly soluble (0.12 g/l) (25 o C),
  • PSA: 90.38000
  • LogP: 3.24380

ortho Gliclazide Security Information

ortho Gliclazide Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
G409880-100mg
ortho Gliclazide
1076198-18-9
100mg
$ 221.00 2023-09-07
TRC
G409880-1g
ortho Gliclazide
1076198-18-9
1g
$ 1669.00 2023-09-07
XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd.
G0326012
ortho Gliclazide
1076198-18-9 European Pharmacopoeia (EP) Reference Standard
¥2654.27 2022-02-23
XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd.
BP366
Gliclazide impurity F
1076198-18-9 British Pharmacopoeia (BP) Reference Standard
¥2261.2 2022-02-22
Chemenu
CM197333-1g
N-((hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-2-methylbenzenesulfonamide
1076198-18-9 95%
1g
$899 2023-03-07
XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd.
-30mg
Gliclazide impurity F
1076198-18-9
30mg
¥1897.11 2023-09-09
TRC
G409880-1000mg
ortho Gliclazide
1076198-18-9
1g
$1669.00 2023-05-18
XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd.
BP366
1076198-18-9
30MG
¥2339.9 2023-01-06
XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd.
G0326012
1076198-18-9
¥1556.7 2023-01-14
XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd.
BP366-30mg
Gliclazide impurity F
1076198-18-9
30mg
¥1958.23 2025-01-16
Recommended suppliers
Shenzhen Yaoyuan R&D Center Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shenzhen Yaoyuan R&D Center Co.,Ltd
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd
Wuhan ChemNorm Biotech Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Wuhan ChemNorm Biotech Co.,Ltd.
Beyond Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Amadis Chemical Company Limited